Vaccines for women age 50 and older
- PMID: 15550213
- PMCID: PMC3328999
- DOI: 10.3201/eid1011.040469
Vaccines for women age 50 and older
Abstract
For older populations, most of whom are women, preventing illnesses and deaths through the use of vaccines is a leading public health challenge. Our understanding about how age and sex affect the immune system is limited, and basic and translational research aimed at improving vaccines and immune responses of older persons is needed. In the meantime, fully implementing current vaccine recommendations, particularly those for influenza and pneumococcal vaccines, can save thousands of lives and prevent illnesses in persons > 50 years of age.
Figures

References
-
- Centers for Disease Control and Prevention. Prevention and control of influenza. MMWR Morb Mortal Wkly Rep. 2004;53:1–40. - PubMed
-
- Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997;46(RR-8):1–24. - PubMed
-
- Centers for Disease Control and Prevention. Hepatitis B virus: a comprehension strategy for eliminating transmission in the United States through universal childhood vaccination; recommendations of the Immunization practices Advisory Committee (ACIP). MMWR Recomm Rep. 1991;40(RR-13):1–25. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical